Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency - Charles-Edwards, Geoffrey; Amaral, Nelson; Sleigh, Alison; Ayis, Salma; Catibog, Norman; McDonagh, Theresa; Monaghan, Mark; Amin-Youssef, George; Kemp, Graham J; Shah, Ajay M; Okonko, Darlington O (Circulation (New York, N.Y.), 2019)
Keywords: Aged; Aged, 80 and over; Anemia, Iron-Deficiency - blood; Anemia, Iron-Deficiency - diagnosis; Anemia, Iron-Deficiency - drug therapy; Biomarkers - blood; Disaccharides - adverse effects; Disaccharides - therapeutic use; Double-Blind Method; Energy Metabolism - drug effects; Exercise Tolerance - drug effects; Female; Ferric Compounds - adverse effects; Ferric Compounds - therapeutic use; Heart Failure - diagnosis; Heart Failure - drug therapy; Heart Failure - physiopathology; Hematinics - adverse effects; Hematinics - therapeutic use; Humans; Iron - blood; Iron Deficiencies; London; Magnetic Resonance Spectroscopy; Male; Middle Aged; Muscle, Skeletal - drug effects; Muscle, Skeletal - metabolism; Muscle, Skeletal - physiopathology; Phosphocreatine - metabolism; Recovery of Function; Time Factors; Treatment Outcome; London; heart failure; iron; muscles; energy metabolism